Scientists have deciphered a key strategy of cancer cells that allows them to outfox the immune system and enhance the odds of their survival by employing a deadly "two-faced protein" that is reminiscent of a two-faced figure ...
Understanding the mechanisms that mediate widespread DNA damage in the cancer genome is of great interest to cancer physicians and scientists because it may lead to improved treatments and diagnosis. In this study, a multi-institutional ...
10 hours ago
0
36
In continuing efforts to find novel ways to kill cancer cells, researchers at the University of Maryland School of Medicine (UMSOM) have identified a new pathway that leads to the destruction of cancer cells. The new finding, ...
11 hours ago
0
63
When chemotherapy was first invented, its premise seemed relatively simple: to curb the growth of tumors by stopping their cells from proliferating. Today, many of these drugs are known to act through different mechanisms, ...
13 hours ago
0
27
A therapy developed by Yale researchers stimulates immune cells to shrink or kill tumors in mice, according to a new study published in the Journal of Experimental Medicine. The therapy is effective alone or in combination ...
15 hours ago
0
180
Cancer cells are masters at avoiding detection, but a new system developed by Yale scientists can make them stand out from the crowd and help the immune system spot and eliminate tumors that other forms of immunotherapies ...
Oct 14, 2019
0
780
The Griffith University scientists used CRISPR-Cas9 to successfully target and treat cervical cancer tumours in vivo (via injection into live and tumour-bearing mice) using "stealth" nanoparticles.
Oct 10, 2019
0
588
A team of researchers with members from across the Netherlands has found that using organoids derived from patient tumors can be used to help determine how well a cancer patient will respond to chemotherapy. In their paper ...
A unique type of immune cell has been discovered in human breast tissue, and breast cancer patients with more of these cells are more likely to survive, finds new research from the Francis Crick Institute and King's College ...
Oct 09, 2019
0
85
A new, multicenter study led by Fred Hutchinson Cancer Research Center and Memorial Sloan Kettering Cancer Center determined how a single mutation in splicing factor 3b subunit 1 (SF3B1), the most frequently mutated splicing ...
Oct 09, 2019
0
35
